Apolipoprotein(a) phenotype, albumin clearance, and plasma levels of lipoprotein(a) in peritoneal dialysis

被引:2
|
作者
Iliescu, EA
Marcovina, SM
Morton, AR
Koschinsky, ML
机构
[1] Queens Univ, Kingston, ON K7L 3N6, Canada
[2] Univ Washington, Seattle, WA 98195 USA
来源
NEPHRON | 2001年 / 88卷 / 02期
关键词
apolipoprotein(a); lipoprotein(a); peritoneal dialysis; chronic renal failure;
D O I
10.1159/000045979
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
This cross-sectional study was undertaken to examine the relationship between plasma lipoprotein(a) [Lp(a)l level and peritoneal dialysis (PD) albumin clearance while controlling for the influence of the apolipoprotein(a) [apo(a)l phenotype. Plasma Lp(a) level, PD albumin clearance, and apo(a) phenotype thigh vs. low molecular weight, HMW vs. LMW) were determined in 54 PD patients. Apo(a) phenotypes were 24 LMW and 30 HMW. The plasma Lp(a) level was high (> 65 nmol/l) in 17 of 24 patients with LMW phenotype versus 2 of 30 with HMW phenotype (chi (2), p < 0.01). Spearman correlation coefficients of Lp(a) with PD, urine, and total albumin clearances were -0.05 (p = 0.74), -0.04 (p = 0.80), and -0.09 (p = 0.51), respectively. The apo(a) isoform size was the only significant predictor of Lp(a) in multivariate analysis. In this study, there was no association between PD albumin clearance and Lp(a) level. The association between apo(a) phenotype and Lp(a) level is in keeping with studies in the general population. There is a strong genetic influence on Lp(a) level in PD patients. Copyright (C) 2001 S. Karger AG, Basel.
引用
收藏
页码:168 / 169
页数:2
相关论文
共 50 条
  • [41] What should plasma bicarbonate levels be in peritoneal dialysis patients?
    Ortiz, A
    Caramelo, C
    PERITONEAL DIALYSIS INTERNATIONAL, 2003, 23 (06): : 606 - 607
  • [42] Plasma ghrelin levels in patients undergoing haemodialysis and peritoneal dialysis
    Pérez-Fontán, M
    Cordido, F
    Rodriguez-Carmona, A
    Peteiro, J
    Garcia-Naveiro, R
    García-Buela, J
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 (08) : 2095 - 2100
  • [43] EFFECTS OF HEMODIALYSIS AND CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS ON THE PLASMA-CLEARANCE OF AN ALBUMIN-BOUND FURAN DICARBOXYLIC-ACID
    COSTIGAN, MG
    YAQOOB, M
    LINDUP, WE
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1995, 10 (05) : 648 - 652
  • [44] The effect of albumin infusion on serum lipoprotein (A) concentration in patients on continuous ambulatory peritoneal dialysis.
    Yang, WS
    Kim, SB
    Min, WK
    Park, JS
    KIDNEY INTERNATIONAL, 1997, 51 (03) : 958 - 958
  • [45] IMPACT OF ALBUMIN ON PHOSPHORUS IN PERITONEAL DIALYSIS
    Bui, Antiem
    Streja, Elani
    Kalantar-Zadeh, Kamyar
    Sy, John
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2019, 73 (05) : 659 - 659
  • [46] PLASMA-CONCENTRATION AND PERITONEAL CLEARANCE OF OXALATE IN PATIENTS ON CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS (CAPD)
    YAMAUCHI, A
    FUJII, M
    SHIRAI, D
    MIKAMI, H
    OKADA, A
    IMAI, E
    ANDO, A
    ORITA, Y
    KAMADA, T
    CLINICAL NEPHROLOGY, 1986, 25 (04) : 181 - 185
  • [47] Dialysis removes apolipoprotein C-I, improving very low-density lipoprotein clearance
    Kaysen, G. A.
    KIDNEY INTERNATIONAL, 2007, 72 (07) : 779 - 781
  • [48] APOLIPOPROTEIN-E POLYMORPHISM AND PLASMA-LIPID, LIPOPROTEIN, AND APOLIPOPROTEIN LEVELS IN ITALIAN CHILDREN
    XU, CF
    TALMUD, PJ
    ANGELICO, F
    DELBEN, M
    SAVILL, J
    HUMPHRIES, SE
    GENETIC EPIDEMIOLOGY, 1991, 8 (06) : 389 - 398
  • [49] Apolipoprotein E polymorphism has no independent effect on plasma levels of lipoprotein(a)
    Ritter, MM
    Gewitsch, J
    Richter, WO
    Geiss, HC
    Wildner, MW
    Schwandt, P
    ATHEROSCLEROSIS, 1997, 131 (02) : 243 - 248
  • [50] Effects of apolipoprotein A-IV genotype on glucose and plasma lipoprotein levels
    Larson, IA
    Ordovas, JM
    Sun, Z
    Barnard, JR
    Lohrmann, J
    Feussner, G
    Lamon-Fava, S
    Schaefer, EJ
    CLINICAL GENETICS, 2002, 61 (06) : 430 - 436